These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1429067)

  • 1. Clinical improvement of the myopathy in eosinophilia-myalgia syndrome with steroids and rehabilitative therapy.
    Esper JJ; Nigro MA; Wishnow R; Barnett T; Perrotta AL; Richardson W
    J Am Osteopath Assoc; 1992 Aug; 92(8):1056-8. PubMed ID: 1429067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upper extremity contractures in a patient with eosinophilia-myalgia syndrome.
    Marchman HB; Gleason CB; Shaw JC
    Arch Phys Med Rehabil; 1991 Nov; 72(12):1029-30. PubMed ID: 1953317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [L-tryptophan-associated chronic eosinophilia-myalgia syndrome treated with cyclosporin].
    Schubert S; Trautmann F; Dreher R
    Z Rheumatol; 1992; 51(4):158-62. PubMed ID: 1414039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilia-myalgia syndrome: myopathic electrodiagnostic characteristics.
    Tanhehco JL; Wiechers DO; Golbus J; Neely SE
    Muscle Nerve; 1992 May; 15(5):561-7. PubMed ID: 1584247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [L-tryptophan-induced eosinophilia-myalgia syndrome with features of diffuse fasciitis with eosinophilia].
    Senff H; Köllner A; Engelmann L; Woort-Menker M; Mensing H; Kunze J
    Hautarzt; 1990 Oct; 41(10):578-82. PubMed ID: 2258302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilia-myalgia syndrome associated with L-tryptophan use.
    Glickstein SL; Gertner E; Smith SA; Roelofs RI; Hathaway DE; Schlesinger PA; Schned ES
    J Rheumatol; 1990 Nov; 17(11):1534-43. PubMed ID: 2273499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated L-kynurenine level and its normalization by prednisolone in a patient with eosinophilia-myalgia syndrome.
    Hisatomi A; Kubota A; Ohashi M; Umeda F; Nawata H; Imamura T; Nagata T
    Fukuoka Igaku Zasshi; 1997 Jan; 88(1):11-7. PubMed ID: 9037890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-L-tryptophan related eosinophilia-myalgia syndrome with hypoproteinemia and hypoalbuminemia.
    Margolin L
    J Rheumatol; 2003 Mar; 30(3):628-9. PubMed ID: 12610828
    [No Abstract]   [Full Text] [Related]  

  • 9. [Eosinophilia-myalgia syndrome and L-tryptophan intake].
    von Gizycki-Nienhaus B; Meurer M; Krieg T; Braun-Falco O
    Hautarzt; 1991 Mar; 42(3):179-82. PubMed ID: 1829070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuromuscular diseases with eosinophilia].
    Pellissier JF; Figarella-Branger D; Serratrice G
    Med Trop (Mars); 1998; 58(4 Suppl):471-6. PubMed ID: 10410368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophilia-myalgia syndrome associated with L-tryptophan. A case report with pulmonary manifestations and review of the literature.
    André M; Canon JL; Levecque P; Dermine P; Mortier C; Leveau F
    Acta Clin Belg; 1991; 46(3):178-82. PubMed ID: 1656679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The tryptophan-associated eosinophilia-myalgia syndrome. A clinical follow-up of 8 patients].
    Szeimies RM; Meurer M
    Dtsch Med Wochenschr; 1993 Feb; 118(7):213-20. PubMed ID: 8440161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophilic fasciitis is clinically distinguishable from the eosinophilia-myalgia syndrome and is not associated with L-tryptophan use.
    Varga J; Griffin R; Newman JH; Jimenez SA
    J Rheumatol; 1991 Feb; 18(2):259-63. PubMed ID: 2023221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilia-myalgia syndrome in association with L-tryptophan ingestion.
    Gresh JP; Vasey FB; Espinoza LR; Adelman HM; Germain BF
    J Rheumatol; 1990 Nov; 17(11):1557-8. PubMed ID: 2273503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilia-myalgia syndrome: a clinicopathological study of four patients.
    Villanova M; De Clerck LS; Cras P; Ceuterick C; Van Marck E; Guazzi GC; Martin JJ
    Clin Neuropathol; 1993; 12(4):201-3. PubMed ID: 8403629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Eosinophilia-myalgia syndrome. Clinical aspects and follow-up of 10 patients].
    Mensing H; Schallreuter KU; Senff H; Steinkraus V
    Hautarzt; 1992 Jul; 43(7):436-40. PubMed ID: 1506202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Analysis of four patients and implications for differential diagnosis and pathogenesis.
    Strongwater SL; Woda BA; Yood RA; Rybak ME; Sargent J; DeGirolami U; Smith TW; Varnis C; Allen S; Murphy K
    Arch Intern Med; 1990 Oct; 150(10):2178-86. PubMed ID: 2222105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Eosinophilia-myalgia syndrome after L-tryptophan intake].
    Zillikens D; Bammel A; Lurz C; Elsner P; Burg G
    Hautarzt; 1991 Mar; 42(3):154-7. PubMed ID: 2055764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophilia-myalgia syndrome: a recent syndrome serving as an alert to new diseases ahead.
    Sidransky H
    Mod Pathol; 1994 Sep; 7(7):806-10. PubMed ID: 7824518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of antineutrophil cytoplasmic antibody in a patient with L-tryptophan induced eosinophilia-myalgia syndrome.
    Cilursu AM; Goeken J; Olson RR
    Ann Rheum Dis; 1991 Nov; 50(11):817-9. PubMed ID: 1772299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.